2',5'-Dideoxyadenosine是一种强效的非竞争性腺苷酸环化酶抑制剂,IC50 为 3 μM,作为核苷酸类类似物,主要在心脏发挥抗交感神经作用。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | 2',5'-Dideoxyadenosine effectively inhibits adenylyl cyclase in a non-competitive manner by binding to the P-site, with an IC50 of 3 µM. It is a nucleoside analog and exhibits strong antiadrenergic effects in the heart[1][2]. |
| 体内研究 | 2',5'-Dideoxyadenosine (0.1 mg/kg; IP; 15 min pre-treated) completely blocks the diuretic, natriuretic, and K+ and Cl- sparing effects of Fr EtOAc in rats[4]. |
| 体外研究 | 2',5'-Dideoxyadenosine (10 μM, 30 min) decreases cAMP production and inhibits the phosphorylation of GluA1 at Ser845, which is induced by carbachol (CCh)[3]. 2',5'-Dideoxyadenosine (10 μM, 30 min) inhibits the carbachol (CCh)-induced increase in Akt phosphorylation and reduces CCh-induced phosphorylation at Ser2448[3]. 2',5'-Dideoxyadenosine (20-150 mM), like adenosine, dependently and reversibly reduces the positive inotropic and chronotropic effects of beta-adrenergic stimulation with isoproterenol (8-54 pmol) by up to 70% and 50%, respectively[2]. |
| Concentration | Treated Time | Description | References | |
| MIN6 β-cells | 100 μM | inhibited glucose-induced [cAMP]pm oscillations | Diabetes. 2011 May;60(5):1535-43. | |
| Human T lymphocytes | 100 μM - 1 mM | 5 min | Partially inhibited the directed movement (capping process) of CD3, CD4, and CD8 molecules; at 1 mM ddAdo, only half of the cells were able to cap. | Proc Natl Acad Sci U S A. 1988 Feb;85(3):792-6 |
| L6 myotubes | 50 μM | 30min | Inhibited adenylate cyclase, significantly reducing cAMP accumulation stimulated by zinterol (100 nM) or forskolin (10 μM), and partially inhibited zinterol-stimulated glucose uptake. | Br J Pharmacol. 2006 Feb;147(4):446-54 |
| mouse pancreatic islet β-cells | 100 μM | suppressed the glucose- and hormone-induced [cAMP]pm elevations | Diabetes. 2011 May;60(5):1535-43. | |
| SH-SY5Y cells | 300 μM | 48 h | To investigate the effect of 2',5'-Dideoxyadenosine on neurite branching and length in SH-SY5Y cells, results showed that the compound attenuated the promoting effect of VILIP-1 overexpression on neurite branching and length. | Transl Psychiatry. 2011 Jul 19;1(7):e22 |
| rat thoracic aorta endothelial cells | 50 μM | inhibited adenyl cyclase activity, thereby reducing NO release evoked by adenosine via A1 and A2A receptors | J Physiol. 2002 Oct 1;544(Pt 1):195-209 | |
| SPG15 patient-derived fibroblasts | 10 μM | 24 h | Reduced autophagosome accumulation and decreased LC3-II levels | Brain. 2023 Mar 1;146(3):1103-1120 |
| Administration | Dosage | Frequency | Description | References | ||
| Drosophila | SPG15 loss of function model | Oral | 30 μM | Chronic treatment | Improved lysosome biogenesis and function, reduced autophagosome accumulation | Brain. 2023 Mar 1;146(3):1103-1120 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
4.25mL 0.85mL 0.43mL |
21.25mL 4.25mL 2.13mL |
42.51mL 8.50mL 4.25mL |
|
| CAS号 | 6698-26-6 |
| 分子式 | C10H13N5O2 |
| 分子量 | 235.24 |
| SMILES Code | C[C@H]1O[C@H](C[C@@H]1O)N1C=NC2=C1N=CN=C2N |
| MDL No. | MFCD00210904 |
| 别名 | NSC 95943 |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, inert atmosphere, store in freezer, under -20°C |
| 溶解方案 |
DMSO: 120 mg/mL(510.11 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1